PAMS
CERE

Pictet Asset Management (Switzerland)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,577
Closed -$239K – 2032
2022
Q4 		$239K Buy
+7,577
New +$239K ﹤0.01% 1619